ITHS CTMS Program Office

Visit Website

This Clinical Trial Management System offers a centralized, web-based platform integrating oncology and non-oncology research management across Fred Hutch Cancer Center and University of Washington, featuring streamlined regulatory tracking, billing compliance, and cross-institutional collaboration.

Overview

The CTMS Program Office is a collaborative effort between Fred Hutch Cancer Center and the University of Washington, aimed at improving the efficiency and effectiveness of managing clinical research. It centralizes a wide array of functionalities through the OnCore system, geared towards streamlining clinical trials, including both oncology and non-oncology studies. This positions the CTMS Program Office as a significant player in the clinical trial management industry, particularly within the academic and research institution markets, leveraging their comprehensive management software to facilitate complex clinical research processes.

Products & Services

The CTMS Program Office offers the OnCore Clinical Trial Management System, a sophisticated web-based platform that enhances clinical research management. The system provides capabilities such as managing study start-up and amendments, tracking regulatory approvals, providing access to study documents, and ensuring compliance with billing operations. It serves study teams, central offices, and clinic teams, offering comprehensive support for financial and billing processes as well as facilitating integration with existing systems like UW/Fred Hutch Epic Electronic Medical Records.

Company Details

Located within the partnership framework of Fred Hutch Cancer Center and the University of Washington, the CTMS Program Office primarily serves the clinical research sector within these institutions. This collaboration reflects a solid commitment to integrating clinical research and administrative functionalities, optimizing service delivery to academic institutions in the Seattle region. Founded through the union of two prestigious entities, it taps into an extensive network of research and medical expertise to enhance clinical trials management substantially.